CapsoVision, Inc. Common Stock (CV) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.638x

Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has a cash flow conversion efficiency ratio of -0.638x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.40 Million) by net assets ($13.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CapsoVision, Inc. Common Stock (CV) total market value for the company's overall valuation and market capitalisation.

CapsoVision, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)

This chart illustrates how CapsoVision, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CapsoVision, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their cash flow conversion efficiency. See debt repayment capacity of CapsoVision, Inc. Common Stock to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
BLD Plantation Bhd
KLSE:5069
-0.051x
KOSES Co.Ltd
KQ:089890
0.044x
Pinlive Foods Co Ltd
SHE:300892
0.009x
Tien Phong Securities Corp
VN:ORS
-0.249x
Banvit Bandirma Vitaminli Yem Sanayi AS
IS:BANVT
-0.067x
Galectin Therapeutics Inc
NASDAQ:GALT
0.030x
ZCCM Investments Holdings Plc
PA:MLZAM
-0.002x
Beijing Seeyon Internet Software Cp
SHG:688369
-0.118x

Annual Cash Flow Conversion Efficiency for CapsoVision, Inc. Common Stock (2023–2025)

The table below shows the annual cash flow conversion efficiency of CapsoVision, Inc. Common Stock from 2023 to 2025. View CapsoVision, Inc. Common Stock (CV) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $13.26 Million $-22.86 Million -1.724x -1211.50%
2024-12-31 $-129.51 Million $-20.09 Million 0.155x +57.75%
2023-12-31 $-109.84 Million $-10.80 Million 0.098x --

About CapsoVision, Inc. Common Stock

NASDAQ:CV USA Medical Devices
Market Cap
$316.80 Million
Market Cap Rank
#14648 Global
#3468 in USA
Share Price
$6.33
Change (1 day)
+5.68%
52-Week Range
$4.46 - $14.42
All Time High
$14.42
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more